Efficacy and Safety of Erenumab in Preventive and Therapeutic Treatment of Patients Suffering from Migraine. (PubMed, Ann Afr Med) - Sep 27, 2026 - "Erenumab subcutaneous once monthly was the most efficacious treatment regimen and was not associated with a significant risk for treatment related adverse events."
Journal • CNS Disorders • Migraine • Pain
|
|
Arya Vipul Patel; Bhavya Vyas; Devang Ashwinkumar Rana; Priyanka Patel; Siddharth Panchal; Viraj Panchal; Vishwa Parker; Yatri Patel
|